D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 50 Citations 9,338 175 World Ranking 2088 National Ranking 8

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Virus

His primary scientific interests are in Internal medicine, Dengue fever, Immunology, Virology and Retrospective cohort study. His Internal medicine research incorporates themes from Piperacillin/tazobactam, Piperacillin, Surgery and Carbapenem. His Piperacillin research is multidisciplinary, incorporating perspectives in Randomized controlled trial, Meropenem, Beta-lactamase, Drug resistance and Ceftriaxone.

His Dengue fever study integrates concerns from other disciplines, such as Viral disease, Confidence interval, Serology, Severity of illness and Pediatrics. His studies in Virology integrate themes in fields like Antibody, CD8, Communicable disease and Coronavirus. His biological study spans a wide range of topics, including Case-control study and Dengue hemorrhagic fever.

His most cited work include:

  • Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. (1058 citations)
  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. (447 citations)
  • Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. (365 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Dengue fever, Retrospective cohort study, Immunology and Intensive care medicine. His Internal medicine research focuses on Surgery and how it relates to Platelet transfusion. His studies examine the connections between Dengue fever and genetics, as well as such issues in Hematocrit, with regards to Abdominal pain.

His Retrospective cohort study research includes themes of Cohort study, Relative risk, Severity of illness, Intensive care unit and Cohort. His work investigates the relationship between Cohort study and topics such as Prospective cohort study that intersect with problems in Emergency medicine. His study in Ceftriaxone and Carbapenem are all subfields of Antibiotics.

He most often published in these fields:

  • Internal medicine (61.25%)
  • Dengue fever (47.70%)
  • Retrospective cohort study (35.23%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (61.25%)
  • Coronavirus disease 2019 (10.03%)
  • Immunology (24.66%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Coronavirus disease 2019, Immunology, Severe acute respiratory syndrome coronavirus 2 and Antibody are his primary areas of study. Internal medicine is closely attributed to Dengue fever in his research. David C. Lye interconnects Disease severity, Radiography, Virology, Pneumonia and 2019-20 coronavirus outbreak in the investigation of issues within Coronavirus disease 2019.

His Virology study combines topics in areas such as Epitope and Coronavirus. His research in Severe acute respiratory syndrome coronavirus 2 intersects with topics in Gastroenterology and Pandemic. His Antibody research is multidisciplinary, relying on both Virus, Asymptomatic and Convalescence.

Between 2019 and 2021, his most popular works were:

  • Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. (1058 citations)
  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. (447 citations)
  • Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. (365 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Virus

David C. Lye spends much of his time researching Coronavirus disease 2019, Virology, Antibody, Severe acute respiratory syndrome coronavirus 2 and 2019-20 coronavirus outbreak. His Coronavirus disease 2019 research integrates issues from Venous thrombosis, Pediatrics, Disease severity and Acute disseminated encephalomyelitis. His work deals with themes such as Serology, Respiratory tract infections and Coronavirus, which intersect with Virology.

As part of one scientific family, he deals mainly with the area of Antibody, narrowing it down to issues related to the Virus, and often Open reading frame, Genome and Outbreak. His research integrates issues of Observational study, Repeat testing, Pandemic, Betacoronavirus and Cohort in his study of 2019-20 coronavirus outbreak. His research on Pneumonia concerns the broader Internal medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.

Barnaby Edward Young;Sean Wei Xiang Ong;Shirin Kalimuddin;Shirin Kalimuddin;Jenny G. Low;Jenny G. Low.
JAMA (2020)

864 Citations

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.

Jason D. Goldman;David C.B. Lye;David S. Hui;Kristen M. Marks.
The New England Journal of Medicine (2020)

668 Citations

Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures.

Rachael Pung;Calvin J. Chiew;Barnaby E. Young;Sarah Chin.
The Lancet (2020)

461 Citations

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial

Patrick N. A. Harris;Patrick N. A. Harris;Patrick N. A. Harris;Paul A. Tambyah;David C. Lye;David C. Lye;David C. Lye;Yin Mo.
JAMA (2018)

410 Citations

Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients.

Ivan Yu Jun Seah;Danielle E. Anderson;Adrian Eng Zheng Kang;Linfa Wang.
Ophthalmology (2020)

391 Citations

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.

Johanna Hansen;Alina Baum;Kristen E. Pascal;Vincenzo Russo.
Science (2020)

365 Citations

Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.

Yixiang Ng;Zongbin Li;Yi Xian Chua;Wei Liang Chaw.
Morbidity and Mortality Weekly Report (2020)

283 Citations

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.

Chee Wah Tan;Wan Ni Chia;Xijian Qin;Pei Liu.
Nature Biotechnology (2020)

230 Citations

Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey

Ann Versporten;Peter Zarb;Isabelle Caniaux;Marie Françoise Gros.
The Lancet Global Health (2018)

222 Citations

Effects of Early Oseltamivir Therapy on Viral Shedding in 2009 Pandemic Influenza A (H1N1) Virus Infection

Li M. Ling;Angela L. Chow;David C. Lye;Adriana S. Tan.
Clinical Infectious Diseases (2010)

207 Citations

Editorial Boards

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David C. Lye

Yee Sin Leo

Yee Sin Leo

Nanyang Technological University

Publications: 96

Alessandro Sette

Alessandro Sette

La Jolla Institute For Allergy & Immunology

Publications: 60

Lisa F. P. Ng

Lisa F. P. Ng

Agency for Science, Technology and Research

Publications: 56

Paul A. Tambyah

Paul A. Tambyah

National University of Singapore

Publications: 41

Eng Eong Ooi

Eng Eong Ooi

National University of Singapore

Publications: 40

Graham S. Ogg

Graham S. Ogg

University of Oxford

Publications: 40

Peter D. Kwong

Peter D. Kwong

National Institutes of Health

Publications: 36

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 35

Daniela Weiskopf

Daniela Weiskopf

La Jolla Institute For Allergy & Immunology

Publications: 34

Jesse D. Bloom

Jesse D. Bloom

Fred Hutchinson Cancer Research Center

Publications: 34

Pei-Yong Shi

Pei-Yong Shi

The University of Texas Medical Branch at Galveston

Publications: 31

David L. Paterson

David L. Paterson

University of Queensland

Publications: 31

Kwok-Yung Yuen

Kwok-Yung Yuen

University of Hong Kong

Publications: 31

Stephen J. Kent

Stephen J. Kent

University of Melbourne

Publications: 29

Alexander L. Greninger

Alexander L. Greninger

University of Washington

Publications: 29

Michel C. Nussenzweig

Michel C. Nussenzweig

Rockefeller University

Publications: 28

Something went wrong. Please try again later.